Back to Search
ERIC HOLMGREN, M.D.
M.D.
NPI: 1619083565IndividualAccepts Medicare
Specialties, Licenses & Credentials
Dentist
Dentist
Code: 122300000X
04324(NH)016.0002228(VT)
Oral & Maxillofacial Surgery (D.M.D.)Primary
Oral & Maxillofacial Surgery
Code: 204E00000X
18361(NH)227532(MA)
Education
OREGON HEALTH & SCIENCES UNIV SCHOOL OF DENTISTRY
Class of 2004
Research & Publications (20)
Utilization of tracheostomy in craniomaxillofacial trauma at a level-1 trauma center.
PMID 17884529·J Oral Maxillofac Surg·2007
4-observational
Facial soft tissue injuries as an aid to ordering a combination head and facial computed tomography in trauma patients.
PMID 15883940·J Oral Maxillofac Surg·2005
4-observational
Determination and characterization of organic explosives using porous graphitic carbon and liquid chromatography-atmospheric pressure chemical ionization mass spectrometry.
PMID 16213509·J Chromatogr A·2005
8-other
Quantifying the usefulness of PD biomarkers in Phase 2 screening trials of oncology drugs.
PMID 18618429·Stat Med·2008
8-other
Health-related quality of life impact of bevacizumab when combined with irinotecan, 5-fluorouracil, and leucovorin or 5-fluorouracil and leucovorin for metastatic colorectal cancer.
PMID 18776057·Oncologist·2008
3-trial
On-line strategies for determining trace levels of nitroaromatic explosives and related compounds in water.
PMID 17141256·J Chromatogr A·2007
8-other
Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab.
PMID 17686822·J Natl Cancer Inst·2007
1-meta
An adaptive Simon Two-Stage Design for Phase 2 studies of targeted therapies.
PMID 17412647·Contemp Clin Trials·2007
8-other
Impact of vascular endothelial growth factor-A expression, thrombospondin-2 expression, and microvessel density on the treatment effect of bevacizumab in metastatic colorectal cancer.
PMID 16365183·J Clin Oncol·2006
2-rct
Production of a truncated soluble human semicarbazide-sensitive amine oxidase mediated by a GST-fusion protein secreted from HEK293 cells.
PMID 16325418·Protein Expr Purif·2006
8-other
Application of a facial injury severity scale in craniomaxillofacial trauma.
PMID 16487802·J Oral Maxillofac Surg·2006
8-other
Association of k-ras, b-raf, and p53 status with the treatment effect of bevacizumab.
PMID 15998951·J Natl Cancer Inst·2005
8-other
Comparison of the severity of bilateral Le Fort injuries in isolated midface trauma.
PMID 16094579·J Oral Maxillofac Surg·2005
4-observational
Prognostic factors in intraoral squamous cell carcinoma: the influence of histologic grade.
PMID 16243176·J Oral Maxillofac Surg·2005
8-other
Abstracts from the American Association Of Oral And Maxillofacial Surgeons annual scientific meeting: proportion published and time to publication.
PMID 15944983·J Oral Maxillofac Surg·2005
8-other
Bevacizumab in combination with fluorouracil and leucovorin: an active regimen for first-line metastatic colorectal cancer.
PMID 15908660·J Clin Oncol·2005
3-trial
Minimally important differences were estimated for the Functional Assessment of Cancer Therapy-Colorectal (FACT-C) instrument using a combination of distribution- and anchor-based approaches.
PMID 16291468·J Clin Epidemiol·2005
8-other
Facial computed tomography use in trauma patients who require a head computed tomogram.
PMID 15278853·J Oral Maxillofac Surg·2004
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 1 Medical Center Drive, Dartmouth Hitchcock - Oral & Maxillofacial Surgery
Lebanon, NH 03756 - Phone
- (603) 650-5150
Quick Facts
- NPI
- 1619083565
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 4
- Locations
- 2
- Years in Practice
- 22
- Publications
- 20
Are you this provider?
Claim Your Profile